Imaging as a biomarker in drug discovery for Alzheimer's disease: is MRI a suitable technology?

Imaging as a biomarker in drug discovery for Alzheimer's disease: is MRI a suitable technology?

This review provides perspectives on the utility of magnetic resonance imaging (MRI) as a neuroimaging approach in the development of novel treatments for Alzheimer's disease. These considerations were generated in a roundtable at a recent Wellcome Trust meeting that included experts from acade...

Descrición completa

Detalles Bibliográficos
Main Authors:	Merlo Pich, E, Jeromin, A, Frisoni, G, Hill, D, Lockhart, A, Schmidt, M, Turner, M, Mondello, S, Potter, W
Formato:	Journal article
Idioma:	English
Publicado:	BioMed Central 2014

Títulos similares

Advances in Cardiovascular Biomarker Discovery
por: Crystal M. Ghantous, et al.
Publicado: (2020-11-01)

Multinuclear MRI in Drug Discovery
por: Dorota Bartusik-Aebisher, et al.
Publicado: (2022-10-01)

Open drug discovery in Alzheimer's disease
por: Alison D. Axtman, et al.
Publicado: (2023-04-01)

Artificial intelligence for biomarker discovery in Alzheimer's disease and dementia
por: Winchester, LM, et al.
Publicado: (2023)

The role of fMRI in drug discovery.
por: Wise, R, et al.
Publicado: (2006)

Towards an in vitro model of Plasmodium hypnozoites suitable for drug discovery.
por: Laurent Dembele, et al.
Publicado: (2011-03-01)

Metabolomics and Biomarkers for Drug Discovery
por: Pollen K. Yeung
Publicado: (2018-01-01)

Biomarker Discovery and Analysis Platform: Application to Alzheimer's Disease
por: Scott Kuzdzal, et al.
Publicado: (2005-10-01)

MRI predictors of amyloid pathology: results from the EMIF-AD multimodal biomarker discovery study
por: ten Kate, M, et al.
Publicado: (2018)

Dataset of why inclusion matters for Alzheimer's disease biomarker discovery in plasma
por: Mostafa J. Khan, et al.
Publicado: (2021-04-01)

Screening Techniques for Drug Discovery in Alzheimer’s Disease
por: Sandra Maniam, et al.
Publicado: (2024-02-01)

Validation of plasma proteomic biomarkers relating to brain amyloid burden in the EMIF-Alzheimer's disease multimodal biomarker discovery cohort
por: Westwood, S, et al.
Publicado: (2020)

Waste Clearance in the Brain and Neuroinflammation: A Novel Perspective on Biomarker and Drug Target Discovery in Alzheimer’s Disease
por: Kazuhiko Uchida
Publicado: (2022-03-01)

Biomarker methods in drug discovery and development /
por: Wang, Feng
Publicado: (2008)

Association of CSF biomarkers with MRI brain changes in Alzheimer's disease
por: Nazib M Seidu, et al.
Publicado: (2024-01-01)

T1rho MRI and CSF biomarkers in diagnosis of Alzheimer's disease
por: Mohammad Haris, et al.
Publicado: (2015-01-01)

Functional MRI as a biomarker discovery platform for taVNS
por: Roberta Sclocco, et al.
Publicado: (2025-01-01)

Genome-Wide Association Study of Alzheimer’s Disease Brain Imaging Biomarkers and Neuropsychological Phenotypes in the European Medical Information Framework for Alzheimer’s Disease Multimodal Biomarker Discovery Dataset
por: Jan Homann, et al.
Publicado: (2022-03-01)

Biomarkers for Alzheimer's disease therapeutic trials
por: Hampel, H, et al.
Publicado: (2010)

Biomarkers for Alzheimer's disease therapeutic trials.
por: Hampel, H, et al.
Publicado: (2011)

Editorial: Advances in drug discovery for anti-Alzheimer’s agents
por: Lhassane Ismaili
Publicado: (2022-09-01)

Editorial: Liquid-biopsy-guided biomarker and drug discovery
por: Olesya A. Kharenko, et al.
Publicado: (2024-07-01)

Biomarkers to Evaluate Androgen Deprivation Therapy for Prostate Cancer and Risk of Alzheimer’s Disease and Neurodegeneration: Old Drugs, New Concerns
por: Vérane Achard, et al.
Publicado: (2021-12-01)

Biomarkers : in medicine, drug discovery, and environmental health /
por: Vaidya, Vishal S., et al.
Publicado: (c201)

Tissue proteomics : pathways, biomarkers, and drug discovery /
por: Liu, Brian C.-S., et al.
Publicado: (2008)

Proteomic landscape of Alzheimer’s Disease: novel insights into pathogenesis and biomarker discovery
por: Bing Bai, et al.
Publicado: (2021-08-01)

Discovery and Validation of Key Biomarkers Based on Immune Infiltrates in Alzheimer’s Disease
por: Zhuohang Liu, et al.
Publicado: (2021-07-01)

Unveiling Cathepsin B inhibition with repurposed drugs for anticancer and anti-Alzheimer's drug discovery.
por: Mohammed Alrouji, et al.
Publicado: (2024-01-01)

Deep-sequencing of microRNA associated with Alzheimer’s disease in biological fluids: From biomarker discovery to diagnostic practice
por: Lesley eCheng, et al.
Publicado: (2013-08-01)

Association and multimodal model of retinal and blood-based biomarkers for detection of preclinical Alzheimer’s disease
por: Swetha Ravichandran, et al.
Publicado: (2025-01-01)

Mixed pathologies and neural reserve: Implications of complexity for Alzheimer disease drug discovery.
por: David A Bennett
Publicado: (2017-03-01)

MRI as a frontrunner in the search for amyotrophic lateral sclerosis biomarkers?
por: Turner, M
Publicado: (2011)

Discovery of plasma biomarkers related to blood-brain barrier dysregulation in Alzheimer's disease
por: Dan Yuet Ruh
Publicado: (2024)

Biomarker discovery and phytochemical interventions in Alzheimer's disease: A path to therapeutic advances
por: Mithila Debnath, et al.
Publicado: (2025-02-01)

Discovery of plasma biomarkers related to blood-brain barrier dysregulation in Alzheimer’s disease
por: Yuet Ruh Dan, et al.
Publicado: (2024-10-01)

Ensemble feature selection with data-driven thresholding for Alzheimer's disease biomarker discovery
por: Annette Spooner, et al.
Publicado: (2023-01-01)

Alzheimer's disease biomarker discovery using <it>in silico</it> literature mining and clinical validation
por: Greco Ines, et al.
Publicado: (2012-10-01)

A deep learning MRI approach outperforms other biomarkers of prodromal Alzheimer’s disease
por: Xinyang Feng, et al.
Publicado: (2022-03-01)

High-Throughput Transcriptome Profiling in Drug and Biomarker Discovery
por: Xiaonan Yang, et al.
Publicado: (2020-02-01)

AD Informer Set: Chemical tools to facilitate Alzheimer's disease drug discovery
por: Frances M. Potjewyd, et al.
Publicado: (2022-01-01)